Pneumonia Diagnostics & Technologies Market size is expected to reach US$ 5.57 Bn. by year 2029 at a CAGR of 8.2% during the forecast period. The Pneumonia Diagnostics & Technologies Market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The Pneumonia Diagnostics & Technologies Market report also provides trends by market segments, technology, and investment with a competitive landscape.To know about the Research Methodology :- Request Free Sample Report
Pneumonia Diagnostics & Technologies Market Overview:
Pneumonia is an infection in one or both lungs caused by bacteria, viruses, and fungi. The contamination causes inflammation in the air sacs present in the lungs, known as alveoli. The alveoli get filled with fluid or pus and make it difficult for the lungs to breathe. The infection can be life-threatening to any individual if not treated early, most probably in infants, children, and people over 65. Pneumonia symptoms include a cough with phlegm or pus, fever, chills, and difficulty breathing.Pneumonia Diagnostics & Technologies Market Dynamics:
Pneumonia diagnostics and technologies are estimated to grow in the future due to the rising population and occurrence of diseases in elderly people and developing advanced technologies in pneumonia diagnostics and high incidence of pneumonia among children as well. Pneumonia causes more childhood deaths as compared to AIDS, malaria, and tuberculosis combined. Nearly all infantile pneumonia deaths are avoidable through proper diagnosis and treatment. As the development in the healthcare sector is boosting more treatments and drugs are innovated to offer prevention from diseases. Recent diagnostic innovations are concurring the market are automated respiratory rate counters together with variation in technologies such as accelerometers, small motion amplification programs, and bioimpedance are some of them, tracheal and chest auscultation with digital processing and examination of respiratory sounds, and host response biomarkers like inflammatory biomarkers like C-reactive protein and procalcitonin, and cardiovascular biomarkers like arginine vasopressin and natriuretic peptides, and exhaled biomarkers like volatile organic compounds. Moreover, the combination of diagnostic and prognostic treatment with recent innovations are estimated to improve the identification of pneumonia and its severity.Pneumonia Diagnostics & Technologies Market Segment Analysis:
By Product Type, Streptococcus-based, Legionella-based, Chlamydophila based, Viral Pneumonia-based, Mycoplasma Pneumonia-based. The segment Streptococcus-based is dominating the pneumonia diagnosis and technologies market in the forecast period. The streptococcus-based product type was estimate to be the largest in the pneumonia diagnostics market at the end of 2022. Streptococcus pneumonia is spread from one to another by airborne contamination or direct exposure to the bacteria droplets via coughing or sneezing from an infected person. The streptococcus-based segment was valued at more than USD 107 million in 2017. Streptococcus-based pneumonia is considered an aggressive form of infection with an incidence of 10 to 100 cases per population of 100,000 globally. The viral pneumonia-based segment is estimated to bag the highest CAGR in the pneumonia diagnostics market. The viral pneumonia segment of the pneumonia diagnostics market is estimated to reach USD 182 million in the forecast period making. Viral-based pneumonia is alleged to cause approximately 8% of all cases of community-acquired pneumonia in the cases where patients required hospitalization for the treatment.Pneumonia Diagnostics & Technologies Market Regional Insights:
Pneumonia Diagnostics & Technologies Market Regional Insights is segmented into North America, Asia Pacific, Latin America, Europe, Middle East, and Africa.
North America has the maximum share in the pneumonia diagnostics market and is dominating the regional segment of the pneumonia diagnostics and technology market. The North America pneumonia diagnostics market is anticipated to USD 201.2 million by the end of the forecast period. The US is dominating the country in North America due to world-class healthcare infrastructure and elderly population more liable to pneumonia and has grabbed larger opportunities than Canada in the North America pneumonia diagnostics market. High awareness about pneumonia and its devastating effects on infants and the elderly are further boosting the demand for pneumonia treatment in the region. In Europe, the Western Europe pneumonia diagnostics market is estimated to grow with a strong CAGR of 6.4% in the forecast period 2023-2029, making it a region more beneficial in the treatment of the global pneumonia diagnostics market. Moreover, Germany is concurring more attraction as compared to the UK. The objective of the report is to present a comprehensive analysis of the global Pneumonia Diagnostics & Technologies Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report helps in understanding the global Pneumonia Diagnostics & Technologies Market dynamics, structure by analyzing the market segments and project the global Pneumonia Diagnostics & Technologies Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the global Pneumonia Diagnostics & Technologies Market make the report investor’s guide.Pneumonia Diagnostics & Technologies Market Scope: Inquire before buying
Pneumonia Diagnostics & Technologies Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2017 to 2022 Market Size in 2022: US $ 3.21 Bn. Forecast Period 2023 to 2029 CAGR: 8.2% Market Size in 2029: US $ 5.57 Bn. Segments Covered: by Product Type • Streptococcus-based • Legionella based • Chlamydophila based • Viral Pneumonia-based • Mycoplasma Pneumonia-based Pneumonia Diagnostics & Technologies Market, by Region
• North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America)Pneumonia Diagnostics & Technologies Market Key Player
• Becton Dickinson • Affymetrix • Bio-Rad • Abbott Laboratories • Roche • Thermo Fisher Scientific • bioMeriux • DiaSorin and Novartis Diagnostics • Directigen S. pneumonia test kit by Becton Dickinson • LCx Chlamydia pneumonia • Abbott Laboratories • Enzo Biochem • Fujirebio • Grifols • GSK Biologicals • Hologic • Leica Biosystems • Lonza • Ortho-Clinical Diagnostics Frequently Asked Questions: 1. Which region has the largest share in Global Pneumonia Diagnostics & Technologies Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Pneumonia Diagnostics & Technologies Market? Ans: The Global Pneumonia Diagnostics & Technologies Market is growing at a CAGR of 8.2% during forecasting period 2023-2029. 3. What is scope of the Global Pneumonia Diagnostics & Technologies Market report? Ans: Global Pneumonia Diagnostics & Technologies Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Pneumonia Diagnostics & Technologies Market? Ans:The important key players in the Global Pneumonia DiagnosticsTechnologies Market are Becton Dickinson,Affymetrix,Bio-Rad,Abbott Laboratories,Roche,Thermo Fisher Scientific,bioMeriux,DiaSorin and Novartis Diagnostics,Directigen S. pneumonia test kit by Becton Dickinson,LCx Chlamydia pneumonia,Abbott Laboratories,Enzo Biochem,Fujirebio,Grifols,GSK Biologicals,Hologic,Leica Biosystems,Lonza,Ortho-Clinical Diagnostics 5. What is the study period of this Market? Ans: The Global Pneumonia Diagnostics & Technologies Market is studied from 2022 to 2029.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Pneumonia Diagnostics & Technologies Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Pneumonia Diagnostics & Technologies Market 3.4. Geographical Snapshot of the Pneumonia Diagnostics & Technologies Market, By Manufacturer share 4. Global Pneumonia Diagnostics & Technologies Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Grades 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Pneumonia Diagnostics & Technologies Market 5. Supply Side and Demand Side Indicators 6. Global Pneumonia Diagnostics & Technologies Market Analysis and Forecast, 2022-2029 6.1. Global Pneumonia Diagnostics & Technologies Market Size & Y-o-Y Growth Analysis. 7. Global Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 7.1. Other Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 7.1.1. Streptococcus-based 7.1.2. Legionella based 7.1.3. Chlamydophila based 7.1.4. Viral Pneumonia-based 7.1.5. Mycoplasma Pneumonia-based 8. Global Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 9.1.1. Streptococcus-based 9.1.2. Legionella based 9.1.3. Chlamydophila based 9.1.4. Viral Pneumonia-based 9.1.5. Mycoplasma Pneumonia-based 10. North America Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 12. Canada Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 13. Mexico Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 14. Europe Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 15. Europe Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 17. France Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 18. Germany Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 19. Italy Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 20. Spain Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 21. Sweden Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 22. CIS Countries Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 23. Rest of Europe Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 24. Asia Pacific Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 25. Asia Pacific Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 27. India Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 28. Japan Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 29. South Korea Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 30. Australia Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 31. ASEAN Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 32. Rest of Asia Pacific Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 33. Middle East Africa Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 34. Middle East Africa Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 36. GCC Countries Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 37. Egypt Textile Reinforced Concrete e Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 38. Nigeria Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 39. Rest of ME&A Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 40. South America Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 41. South America Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 43. Argentina Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 44. Rest of South America Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Pneumonia Diagnostics & Technologies Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. PerkinElmer 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Grade Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Becton Dickinson 45.3.3. Affymetrix 45.3.4. Bio-Rad 45.3.5. Abbott Laboratories 45.3.6. Roche 45.3.7. Thermo Fisher Scientific 45.3.8. bioMeriux 45.3.9. DiaSorin and Novartis Diagnostics 45.3.10. Directigen S. pneumonia test kit by Becton Dickinson 45.3.11. LCx Chlamydia pneumonia 45.3.12. Abbott Laboratories 45.3.13. Enzo Biochem 45.3.14. Fujirebio 45.3.15. Grifols 45.3.16. GSK Biologicals 45.3.17. Hologic 45.3.18. Leica Biosystems 45.3.19. Lonza 45.3.20. Ortho-Clinical Diagnostics 46. Primary Key Insights